{"id":837966,"date":"2025-04-16T08:21:15","date_gmt":"2025-04-16T12:21:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/"},"modified":"2025-04-16T08:21:15","modified_gmt":"2025-04-16T12:21:15","slug":"nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/","title":{"rendered":"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE, April  16, 2025  (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before market open on Tuesday, April 29, 2025.<\/p>\n<p>The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n3B3iWC_k_hTbbv5DwnZ1YIEjEHQlmP9HkW5-01nwGboaISNruGqxNSDferrmLH7g_UmFWTsuFmkrd3ne37nOJfW-EloXEedDSQBET9DyUQ=\" rel=\"nofollow\" target=\"_blank\">www.nautilus.bio<\/a>.<\/p>\n<p>\n        <strong>About Nautilus Biotechnology, Inc.<\/strong><br \/>\n        <br \/>With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus\u2019 mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n3B3iWC_k_hTbbv5DwnZ1dnlOgQXHJjzZkRrQ2kMUMj18CMXiwoKsnQNWquGo0D-mrZDZAROQ0Yfd52m8OH_o_Z_yWq7-hoSxpuMdiSjssY=\" rel=\"nofollow\" target=\"_blank\">www.nautilus.bio<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>press@nautilus.bio<\/p>\n<p>\n        <strong>Investor Contact <\/strong><br \/>\n        <br \/>investorrelations@nautilus.bio<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmQyN2ViMWMtZmMzNi00OTk1LTkwNjAtOGRkYmUwMGFiNmE2LTEyMTk4NjUtMjAyNS0wNC0xNi1lbg==\/tiny\/Nautilus-Biotechnology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before market open on Tuesday, April 29, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at:\u00a0www.nautilus.bio. About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837966","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before market open on Tuesday, April 29, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at:\u00a0www.nautilus.bio. About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a &hellip; Continue reading &quot;Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-16T12:21:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025\",\"datePublished\":\"2025-04-16T12:21:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/\"},\"wordCount\":182,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/\",\"name\":\"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=\",\"datePublished\":\"2025-04-16T12:21:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/","og_locale":"en_US","og_type":"article","og_title":"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - Market Newsdesk","og_description":"SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before market open on Tuesday, April 29, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at:\u00a0www.nautilus.bio. About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a &hellip; Continue reading \"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-16T12:21:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025","datePublished":"2025-04-16T12:21:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/"},"wordCount":182,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/","name":"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=","datePublished":"2025-04-16T12:21:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE5OCM2ODY4NDk4IzIyMDgzMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-first-quarter-2025-financial-results-on-april-29-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837966"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837966\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}